692 F. App'x 270
6th Cir.2017Background
- Defendant Darryl Gilliam-French was investigated for selling heroin; four controlled buys (packs/capsules typically sold as $10 per pack) were recorded between July–September 2015.
- At arrest and search, officers seized a $300 MoneyGram check, receipts for money orders, $13,424 in cash, scales, small amounts of other drugs, and five suspected heroin capsules.
- Lab testing of samples from the controlled buys confirmed heroin but produced lower per-capsule weights (due in part to heroin sticking to transport bags); informants and customers consistently reported 0.1 g capsules sold for $10.
- The PSR converted the seized cash to an attributable drug weight using a $10 per 0.1 g conversion, yielding 137.24 grams and a base offense level of 24 (Guidelines 57–71 months).
- Gilliam-French objected, arguing conversion should use lab-derived per-capsule weights (which would yield about 69.17 grams and a lower Guidelines range); the district court overruled the objection and imposed a 65-month sentence.
- On appeal the Sixth Circuit reviewed the drug-weight finding for clear error and affirmed, concluding the district court’s conversion ratio ($10 per 0.1 g) was a permissible view of the evidence.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Proper conversion ratio to convert seized cash into attributable drug weight | Government: PSR conversion $10 per 0.1 g based on controlled buys, customer testimony, price/slang evidence | Gilliam-French: use lab-extracted weights from controlled buys (lower per-capsule weight), yielding a lower drug weight | Court upheld $10 per 0.1 g as a plausible view of the evidence; not clearly erroneous |
| Reliability of lab weights from controlled buys | N/A (government relied on investigative testimony over lab weights) | Lab weights are best and most reliable evidence; extraction loss invalidates $10/0.1 g assumption | Court found lab testing purpose was identification, not precise weighing; explained loss and treated lab weights as not dispositive |
| Whether district court considered permissible factors under Guidelines §2D1.1 nt.5 | Government: court may consider price, records, similar transactions, customer testimony | Gilliam-French: court improperly relied on conversion that inflated weight | Court applied Note 5 factors (price, proceeds, similar transactions, length of sales) and reasonably concluded PSR estimate was conservative |
| Procedural reasonableness / clear-error review of sentencing | N/A | Gilliam-French: miscalculation of drug weight rendered Guidelines placement procedurally unreasonable | Court declined to reverse; factual finding on drug quantity not clearly erroneous; sentence affirmed |
Key Cases Cited
- United States v. Bolds, 511 F.3d 568 (6th Cir. 2007) (standard of appellate review for sentencing decisions)
- Gall v. United States, 552 U.S. 38 (2007) (abuse-of-discretion standard for sentencing review)
- United States v. Russell, 595 F.3d 633 (6th Cir. 2010) (government must prove money attributable to drug activity and conversion ratio)
- United States v. Johnson, 732 F.3d 577 (6th Cir. 2013) (when uncertain, court must err on side of caution and attribute only what is more likely than not)
- United States v. Pawlak, 822 F.3d 902 (6th Cir. 2016) (miscalculating Guidelines can make sentence procedurally unreasonable)
- Molina-Martinez v. United States, 136 S. Ct. 1338 (2016) (effects of Guidelines miscalculation on sentencing review)